D.E. Shaw & Co
OCGN icon

D.E. Shaw & Co’s Ocugen OCGN Stock Holding History

D.E. Shaw & Co’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-139,025
Closed -$55.6K – 4514
2023
Q3 		$55.6K Sell
139,025
-953,244
-87% -$471K ﹤0.01% 3909
2023
Q2 		$593K Buy
+1,092,269
New +$700K ﹤0.01% 3354
2022
Q2 		– Sell
-34,306
Closed -$113K – 5639
2022
Q1 		$113K Buy
+34,306
New +$121K ﹤0.01% 4979

Other funds holding OCGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

D.E. Shaw & Co's OCGN Position: Q4 2023 in Review

D.E. Shaw & Co sold out of Ocugen (OCGN) in Q4 2023, closing a stake of 139,025 shares — an estimated $55.6K sold.

D.E. Shaw & Co first reported a position in OCGN in Q1 2022 and held it in 3 quarters. The position peaked at $593K in Q2 2023. 68 funds tracked by Wall St. Rank hold OCGN as of Q4 2023.

  • D.E. Shaw & Co reported no remaining Ocugen position as of Q4 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 139,025 Ocugen shares in Q4 2023, an estimated $55.6K.
  • D.E. Shaw & Co first reported a position in Ocugen in Q1 2022 and held it in 3 quarters.
  • D.E. Shaw & Co's Ocugen position peaked at $593K in Q2 2023.
  • 68 funds tracked by Wall St. Rank held Ocugen as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.